Antimicrobials | Susceptible (S)/Susceptible, increased exposure (I)/Resistant (R), %a | |||||||
---|---|---|---|---|---|---|---|---|
2009b | 2010-2011b | 2012b | 2013b | 2014–2015 | 2017 | 2018–2019 | Totalb | |
n = 81 | n = 78 | n = 75 | n = 101 | n = 73 | n = 36 | n = 78 | n = 522 | |
CRO | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 |
CFM | 100/NA/0 | 100/NA/0 | 100/NA/0 | 98.0/NA/2.0 | 100/NA/0 | 77.8/NA/22.2 | 94.9/NA/5.1 | 97.3/NA/2.7 |
AZM | 98.8/NA/1.2 | 100/NA/0 | 98.7/NA/1.3 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 97.4/NA/2.6 | 99.2/NA/0.8 |
SPC | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 | 100/NA/0 |
CIP | 65.4/0/34.6 | 64.1/2.6/33.3 | 78.7/0/21.3 | 72.3/0/27.7 | 90.4/0/9.6 | 69.4/0/30.6 | 83.3/0/16.7 | 74.9/0.4/24.7 |
PEN | 29.6/60.5/9.9 | −/−/− | 62.6/30.7/6.7 | 59.4/31.7/8.9 | 80.8/16.4/2.8 | 55.6/33.3/11.1 | 51.3/44.9/3.8 | 56.3/36.7/7.0 |
TET | 55.5/21/23.5 | 56.4/10.3/33.3 | 56/9.3/34.7 | 62.4/8.9/28.7 | 76.7/5.5/17.8 | 69.4/0/30.6 | 61.5/11.5/26.9 | 61.9/10.3/27.8 |
GEN | 72.8/27.2/0 | 97.4/2.6/0 | 58.7/41.3/0 | 40.6/59.4/0 | 67.1/32.9/0 | 55.6/44.4/0 | 87.2/12.8/0 | 68.4/31.6/0 |